10 Aug Hope versus experience in glioblastoma
Development of new drugs for this hard-to-treat brain cancer is a slow and incremental process....
laminar pharma Tag
13 Jul Investment in Spanish biotech is at an all-time high
The Spanish Bioindustry Association (AseBio), where Laminar Pharma is a member, has published its latest annual report on the state of the biotech sector in Spain, with updated data from 2020. ...
01 Dec We have surpassed our €1.2M target in the latest round of financing
The Spanish government has announced the public grants corresponding to the State Program for research, development and innovation call — geared towards societal challenges and called "Collaboration Challenges of the year 2019". These are instruments to help meet the needs of the Spanish Science, Technology...
20 Nov We’ve been awarded €1M grant by the Ministry of Science to study brain tumor biomarkers with Fundación Rioja Salud and the University of the Balearic Islands
The Spanish government has announced the public grants corresponding to the State Program for research, development and innovation call — geared towards societal challenges and called "Collaboration Challenges of the year 2019". These are instruments to help meet the needs of the Spanish Science, Technology...
20 Nov Spanish biotech company Laminar, the Fundación Rioja Salud and the University of the Balearic Islands will receive one million euros from the Ministry of Science and Innovation to study brain tumor biomarkers
[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column width="5/6"][vc_separator type="transparent" up="35"][vc_column_text] From the left, top: Adrian McNicholl, Gema Malet, Pablo V. Escribá, Ignacio Larrayoz, Paula Fernández y Roberto Beteta. Seated: Emilce Cano, Rafael Peláez, Catalina Rosselló, Raquel Rodríguez y Manuel Torres. November 20th, 2020 The Spanish government has announced...
19 Nov The versatility of melitherapy
Many drugs that are available in the market have something in common, regarding how they make effect: they directly target one or more proteins. And this is not a coincidence. Proteins perform a vast range of functions within the cells of all living organisms that...
30 Oct Our team’s review on Membrane Lipid Composition is widely discussed by the scientific community
A recent review article published by Laminar Pharma scientists in IJMS has awoken the interest of the scientific community....
16 Oct Melitherapy: When the surface has deep implications
Many drugs that are available in the market have something in common, regarding how they make effect: they directly target one or more proteins. And this is not a coincidence. Proteins perform a vast range of functions within the cells of all living organisms that...
01 Jul We’re getting ready to join the stock market by end of 2020
Given the good track record of the stock market as an alternative source of financing, our company is taking its first steps to attract private investors and institutions, by joining the MAB stock market before the end of 2020. Nonpublic financing formulas such as Private...
07 Jan Nueva Ronda de financiación superada
En dos meses se puede dar la vuelta al mundo varias veces, incluso dar una vuelta por la Luna si tienes un cohete o mucha imaginación. 60 días dan para dar vueltas a muchas cosas: desde una decisión importante a una tortilla de patatas....
- 1
- 2